Fuji astaxanthin earns GRAS go-ahead
This article was originally published in The Tan Sheet
Executive SummaryFuji Chemical Industry Co. can use AstaREAL astaxanthin in food and beverage applications, following FDA's letter of no objection to the ingredient's generally recognized as safe status. Fuji said Jan. 12 the agency's tacit approval increases U.S. marketing opportunities and global awareness of astaxanthin, a carotenoid antioxidant found in seafood. Charles DePrince, president of the Japanese pharmaceutical company's U.S. subsidiary in Burlington, N.J., said in a release that the firm is committed to quality and safety, and the GRAS notification Fuji submitted in July 2009 includes purity specifications unique to AstaREAL
You may also be interested in...
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.
The EU network of health technology assessment bodies says it is seeing the benefit of systematically involving patients when companies approach it for early scientific advice on evidence generation.
As stockpiles of Ebola vaccine are being built up around the world, Médecins sans Frontières has said more action is needed to ensure sufficient numbers of vaccinations are available for use in current and future outbreaks.